Over 450,000 patients have received a DePuy attune knee implant since the device was brought to market in 2011.
However, defective design issues with the attune knee replacement system have prompted the company and Food and drug administration (FDA) to issue warnings and recall for the potentially dangerous product. If you want to know more about DePuy Knee Lawsuit | Attune Knee Failure Lawsuits then click right here.
Thousands of patients have experienced problems with the attune knee, including tibial loosening, a condition which may require patients to undergo a painful revision surgery to resolve implant complications. Attorneys representing injured patients note that as of July 2017, the FDA’s adverse event reporting database had received around 1,400 reports of implant failures, many of which have resulted in knee revision surgeries.
The FDA originally issued a class ii recall for the attune tibial articulation surface component in June 2015 after receiving numerous reports of attuning knee tibial loosening. According to the recall, a wire spring coil was reportedly loosening and detaching, often quite soon after the device was implanted.
The wire spring coil was found to disassociate from the implant and possibly lodge in the tissue of a patient. Depuy admitted that if the spring coil separated from the knee system, it could enter the surgical site and cause further health issues.
The FDA warned that attune knee tibial loosening was caused by the tibial baseplate loosening, which may lead to infection and inflammation in the surrounding bone and muscle.